Lite Strategy, Inc. (LITS)
$1.22-3.94%Close
BUYCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $42M
- Beta
- 0.04
- P/E (TTM)
- -0.15
- Short % float
- 0.70%
- Days to cover
- 1.0
- SI change
- +121.3%
- 1W
- -12.86%
- 1M
- +9.91%
- vs SPY 1W
- -13.28%
- vs SPY 1M
- +7.85%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on LITS?
- LOPJLB’s latest quantitative signal on Lite Strategy, Inc. (LITS) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is LITS in?
- Lite Strategy, Inc. (LITS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lite Strategy, Inc. (LITS) do?
- Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San…